Correlation Between Cansino Biologics and OptiNose

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cansino Biologics and OptiNose at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cansino Biologics and OptiNose into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cansino Biologics and OptiNose, you can compare the effects of market volatilities on Cansino Biologics and OptiNose and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cansino Biologics with a short position of OptiNose. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cansino Biologics and OptiNose.

Diversification Opportunities for Cansino Biologics and OptiNose

-0.68
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Cansino and OptiNose is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Cansino Biologics and OptiNose in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OptiNose and Cansino Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cansino Biologics are associated (or correlated) with OptiNose. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OptiNose has no effect on the direction of Cansino Biologics i.e., Cansino Biologics and OptiNose go up and down completely randomly.

Pair Corralation between Cansino Biologics and OptiNose

Assuming the 90 days trading horizon Cansino Biologics is expected to generate 0.85 times more return on investment than OptiNose. However, Cansino Biologics is 1.18 times less risky than OptiNose. It trades about 0.19 of its potential returns per unit of risk. OptiNose is currently generating about -0.12 per unit of risk. If you would invest  4,063  in Cansino Biologics on September 12, 2024 and sell it today you would earn a total of  2,786  from holding Cansino Biologics or generate 68.57% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy89.06%
ValuesDaily Returns

Cansino Biologics  vs.  OptiNose

 Performance 
       Timeline  
Cansino Biologics 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Cansino Biologics are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Cansino Biologics sustained solid returns over the last few months and may actually be approaching a breakup point.
OptiNose 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OptiNose has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Cansino Biologics and OptiNose Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cansino Biologics and OptiNose

The main advantage of trading using opposite Cansino Biologics and OptiNose positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cansino Biologics position performs unexpectedly, OptiNose can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OptiNose will offset losses from the drop in OptiNose's long position.
The idea behind Cansino Biologics and OptiNose pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Global Correlations
Find global opportunities by holding instruments from different markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories